Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  PuriCore plc    PURI   GB00B3XBCR18

PURICORE PLC

 (PURI)

0
Delayed Quote. Delayed London Stock Exchange - 05/22 03:00:07 am
40.5 GBp   --.--%
5d ago PURICORE PLC: Interim Management Statement
05/14 PURICORE PLC: Board Changes
04/08 PURICORE PLC: PuriCore Signs Major US Deal: $14 Million
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsForum 

PuriCore plc : PuriCore Raises $3.5 Million

01/03/2012| 03:11pm US/Eastern
Recommend:
0
PuriCore plc ("PuriCore" or the "Company" or the "Group") PuriCore Raises $3.5 Million MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 3 January 2012 - PuriCore (LSE: PURI), the water- based clean technology company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, announces that it closed on a new $3.5 million debt facility with Republic Bank on 29 December 2011. The debt will be utilized to finance the working capital requirements associated with Sterilox Fresh and FloraFresh System installations in H1 2012. The facility is structured as a promissory note with an imputed interest rate of 4%. Enquiries:

FTI Consulting Susan Quigley Ben Brewerton

+44 (0) 20 7831 3113

About PuriCore

PuriCoreplc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. The Company's products are used in a broad range of markets that depend upon controlling contamination, including food retail and foodservice, medical device disinfection, and wound care. PuriCore's solutions are proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of C.difficile, E.coli, HIV, Human and Animal Influenza (including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and Salmonella. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK.
To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.

1

Recommend :
0
Partner Area
React to this article
 
Latest news on PURICORE PLC
5d ago PURICORE PLC: Interim Management Statement
05/14 PURICORE PLC: Board Changes
04/08 PURICORE PLC: PuriCore Signs Major US Deal: $14 Million
04/03 PURICORE PLC: PuriCore Signs Vashe Marketing Agreement with SteadMed Medical
03/06 PURICORE PLC: PuriCore Partners with Onset Dermatologics
03/05 PURICORE PLC: Board and Organizational Changes
02/14 PURICORE PLC: PuriCore Receives FDA 510(k) Clearance for Vashe Skin and Wound H..
2012 PURICORE PLC: Convertible Loan Note Restructuring and Placing
2012 PURICORE PLC: PuriCore Interim Management Statement
2012 PURICORE PLC: PuriCore Partners with Lohas Products GmbH for Water Treatment Ma..
Advertisement
Chart
Duration : Period :
PuriCore plc Technical Analysis Chart | PURI | GB00B3XBCR18 | 4-Traders
Income Statement Evolution
PuriCore plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.